African Health Sciences
Makerere University Medical School
Vol. 20, No. 4, 2020, pp. 1870-1874
Bioline Code: hs20149
Full paper language: English
Document type: Research Article
Document available free of charge
African Health Sciences, Vol. 20, No. 4, 2020, pp. 1870-1874
© Copyright 2020 - Amin HS et al.
Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?|
Amin, Hussein Saad; Arafa, Mostafafa Ahmed; Farhat, Karim Hamda; Rabah, Danny Munther; Altaweel, Abdulaziz Abdullah & Alhammad, Abdulaziz Hamed
Background: Men over 50 should discuss the benefits and harms of prostate-specific antigen (PSA) testing with their
Objectives: To investigate whether shared decision making (SDM) increases the uptake of prostate cancer screening practices
among Saudi men.
Methods: This community-based study recruited men aged ≥ 50 years between January and April 2019. Sociodemographic
characteristics, history, and current medical condition information were collected. SDM information with regards to prostate
cancer screening was discussed.
Results: In total, 2034 Saudi men, aged between 50 and 88 years, agreed to participate in the current study. Prostate examination
for early detection of cancer was recommended for 35.4% (720) of subjects. Of the subjects, 23.3% (473) reported
that the physicians discussed the advantages and benefits of PSA testing, whereas only 5.6% (114) stated that the physicians
explained the disadvantages and drawbacks of PSA testing.
Conclusion: Our findings suggest that less than one fourth discussed the advantages and disadvantages of PSA testing with
their physicians; of these, less than one third underwent PSA blood tests. Improvements are needed in SDM for and against
PSA screening. SDM does not affect the intensity of PSA testing. Primary health care physicians should be actively involved
in the SDM process.
Decision making; prostate cancer screening; low prevalence countries.